Approvals/NMPA/Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)

Approved

生物制品

Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)

Eli Lilly Nederland BV🇨🇳 National Medical Products Administration

Approval Id: 888Q3K22jLi
Approval Number: 国药准字SJ20160043
Generic Name: 精蛋白锌重组赖脯胰岛素混合注射液(25R)
Generic Name En: Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)
Trade Name: 优泌乐25
Brand Name: 优泌乐25
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 3ml:300单位(预装注射笔)
Reg Date: 2025-09-25
Expired Date: 2030-09-24
Company Name: Eli Lilly Nederland BV
Production Company Name: LILLY FRANCE
Company Detail Path: /organization/eli-lilly-nederland-bv
Production Company Detail Path: /organization/lilly-france

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 25, 2025

Approval ID

888Q3K22jLi

Type

生物制品